Avricore Health Stock Operating Margin
| AVCR Stock | CAD 0.08 0.01 14.29% |
Avricore Health fundamentals help investors to digest information that contributes to Avricore Health's financial success or failures. It also enables traders to predict the movement of Avricore Stock. The fundamental analysis module provides a way to measure Avricore Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avricore Health stock.
| Last Reported | Projected for Next Year | ||
| Operating Profit Margin | (0.20) | (0.21) |
Avricore | Operating Margin |
Avricore Health Company Operating Margin Analysis
Avricore Health's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Avricore Health Operating Margin | 0.07 % |
Most of Avricore Health's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avricore Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Avricore Operating Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Avricore Health is extremely important. It helps to project a fair market value of Avricore Stock properly, considering its historical fundamentals such as Operating Margin. Since Avricore Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avricore Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avricore Health's interrelated accounts and indicators.
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Avricore Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Avricore Health has an Operating Margin of 0.068%. This is 100.19% lower than that of the Biotechnology sector and 100.19% lower than that of the Health Care industry. The operating margin for all Canada stocks is 101.23% lower than that of the firm.
Avricore Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avricore Health's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avricore Health could also be used in its relative valuation, which is a method of valuing Avricore Health by comparing valuation metrics of similar companies.Avricore Health is currently under evaluation in operating margin category among its peers.
Avricore Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Avricore Health from analyzing Avricore Health's financial statements. These drivers represent accounts that assess Avricore Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Avricore Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.4M | 5.7M | 14.8M | 30.8M | 16.9M | 17.8M | |
| Enterprise Value | 1.4M | 6.4M | 12.8M | 30.2M | 16.7M | 17.5M |
Avricore Fundamentals
| Return On Equity | -0.0014 | ||||
| Return On Asset | 0.0151 | ||||
| Profit Margin | (0.0007) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 7.83 M | ||||
| Shares Outstanding | 100.94 M | ||||
| Shares Owned By Insiders | 10.19 % | ||||
| Number Of Shares Shorted | 5.75 K | ||||
| Price To Book | 3.24 X | ||||
| Price To Sales | 1.80 X | ||||
| Revenue | 3.49 M | ||||
| Gross Profit | 30.52 K | ||||
| EBITDA | 517.7 K | ||||
| Net Income | (701.22 K) | ||||
| Cash And Equivalents | 122.09 K | ||||
| Total Debt | 40 K | ||||
| Current Ratio | 1.80 X | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | 660.4 K | ||||
| Short Ratio | 0.02 X | ||||
| Beta | -1.89 | ||||
| Market Capitalization | 8.08 M | ||||
| Total Asset | 2.54 M | ||||
| Retained Earnings | (31.74 M) | ||||
| Working Capital | 244.34 K | ||||
| Net Asset | 2.54 M |
About Avricore Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avricore Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avricore Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avricore Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avricore Stock Analysis
When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.